{"transactions":[{"id":722179,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-07-01","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":24.22,"value":14532.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.14 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of\nthe Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":46688,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":722178,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-07-01","kind":"purchase","planned":false,"acquired":true,"shares":4400,"price":23.4,"value":102960.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.14 to $23.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of\nthe Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":46088,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":722177,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":4255,"price":24.98,"value":106289.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.59 to $25.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":41688,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":722176,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":1638,"price":23.88,"value":39115.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.50 to $24.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":37433,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":722175,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":1910,"price":22.95,"value":43834.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.45 to $23.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":35795,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":722174,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:09:53.000Z","date":"2026-06-29","kind":"purchase","planned":false,"acquired":true,"shares":831,"price":23.34,"value":19395.54,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.20 to $23.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":33885,"source":{"system":"sec-edgar","filing":"0001780030-26-000006","document":"form4-07022026_120749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000006/form4-07022026_120749.xml","form_type":"4"}},{"id":725978,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":26.39,"value":2639.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":33054,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725977,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":1358,"price":25.55,"value":34696.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.335 to $26.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":32954,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725976,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":4212,"price":24.9,"value":104878.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.27 to $25.2405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":31596,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725975,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":580,"price":23.61,"value":13693.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.27 to $24.1663, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":27384,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725974,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-24","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":27.77,"value":2777.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":26804,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725973,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-24","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":26.98,"value":91732.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.61 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":26704,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725972,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-24","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":25.98,"value":77940.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.58 to $26.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":23304,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":725971,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:40:29.000Z","date":"2026-06-24","kind":"purchase","planned":false,"acquired":true,"shares":2891,"price":25.22,"value":72911.02,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.50 to $25.435, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":20304,"source":{"system":"sec-edgar","filing":"0001780030-26-000005","document":"form4-06262026_110625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000005/form4-06262026_110625.xml","form_type":"4"}},{"id":728226,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":425,"price":25.91,"value":11011.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.64 to $26.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":17413,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728225,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":1969,"price":24.84,"value":48909.96,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.64 to $25.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":16988,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728224,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":6836,"price":24.12,"value":164884.32,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.62 to $24.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":15019,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728223,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-22","kind":"purchase","planned":false,"acquired":true,"shares":356,"price":23.95,"value":8526.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.82 to $24.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":8183,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728222,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-22","kind":"purchase","planned":false,"acquired":true,"shares":3329,"price":23.28,"value":77499.12,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8003 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":7827,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728221,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-22","kind":"purchase","planned":false,"acquired":true,"shares":1583,"price":22.4,"value":35459.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.79 to $22.7733, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":4498,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728220,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-22","kind":"purchase","planned":false,"acquired":true,"shares":1118,"price":20.82,"value":23276.76,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.62 to $21.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":2915,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":728219,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T22:58:08.000Z","date":"2026-06-22","kind":"purchase","planned":false,"acquired":true,"shares":1797,"price":20.23,"value":36353.31,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.5765 to $20.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Brian Stephenson Revocable Trust (the \"Trust\"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."}],"balance_after":1797,"source":{"system":"sec-edgar","filing":"0001780030-26-000004","document":"form4-06242026_100604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000178003026000004/form4-06242026_100604.xml","form_type":"4"}},{"id":1240823,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option  (right to buy)","published_at":"2025-02-27T22:36:47.000Z","date":"2025-02-25","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023."}],"balance_after":440170,"derivative":{"exercise_price":17,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0000950170-25-029262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025029262/ownership.xml","form_type":"4"}},{"id":1240822,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-02-27T22:36:47.000Z","date":"2025-02-25","kind":"sale","planned":true,"acquired":false,"shares":100,"price":34.18,"value":3418.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."}],"balance_after":102464,"source":{"system":"sec-edgar","filing":"0000950170-25-029262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025029262/ownership.xml","form_type":"4"}},{"id":1240821,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-02-27T22:36:47.000Z","date":"2025-02-25","kind":"sale","planned":true,"acquired":false,"shares":8400,"price":33.1782,"value":278696.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $32.63 to $33.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":102564,"source":{"system":"sec-edgar","filing":"0000950170-25-029262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025029262/ownership.xml","form_type":"4"}},{"id":1240820,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-02-27T22:36:47.000Z","date":"2025-02-25","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":17,"value":144500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."}],"balance_after":110964,"source":{"system":"sec-edgar","filing":"0000950170-25-029262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025029262/ownership.xml","form_type":"4"}},{"id":1260207,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"exercise","planned":true,"acquired":false,"shares":6705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."}],"balance_after":80459,"derivative":{"underlying":"Common Stock","underlying_shares":6705},"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260206,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"exercise","planned":true,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":138947,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260205,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"exercise","planned":true,"acquired":false,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":2840,"derivative":{"underlying":"Common Stock","underlying_shares":946},"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260204,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"exercise","planned":true,"acquired":false,"shares":779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vested on a quarterly basis. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vested on a quarterly basis. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":779},"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260203,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":4148,"price":36.1556,"value":149973.4288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $35.57 to $36.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":102464,"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260202,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":13102,"price":34.9,"value":457259.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,798 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":106612,"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1260201,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2025-02-20T01:50:47.000Z","date":"2025-02-16","kind":"exercise","planned":true,"acquired":true,"shares":25798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 158 shares of the Issuer's Common Stock acquired by the Reporting Person on February 14, 2025 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":119714,"source":{"system":"sec-edgar","filing":"0000950170-25-023630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025023630/ownership.xml","form_type":"4"}},{"id":1290813,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Stock Option  (right to buy)","published_at":"2025-01-30T23:31:19.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":false,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023."}],"balance_after":448670,"derivative":{"exercise_price":17,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0000950170-25-011242","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025011242/ownership.xml","form_type":"4"}},{"id":1290812,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2025-01-30T23:31:19.000Z","date":"2025-01-28","kind":"sale","planned":true,"acquired":false,"shares":68000,"price":36.2906,"value":2467760.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $35.75 to $36.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":93758,"source":{"system":"sec-edgar","filing":"0000950170-25-011242","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025011242/ownership.xml","form_type":"4"}},{"id":1290811,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2025-01-30T23:31:19.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":true,"shares":68000,"price":17,"value":1156000.0,"ownership":{"direct":true},"balance_after":161758,"source":{"system":"sec-edgar","filing":"0000950170-25-011242","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017025011242/ownership.xml","form_type":"4"}},{"id":1334042,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-12-13T00:00:06.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":42683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":42683,"derivative":{"underlying":"Common Stock","underlying_shares":42683},"source":{"system":"sec-edgar","filing":"0000950170-24-135983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024135983/ownership.xml","form_type":"4"}},{"id":1357316,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-11-21T00:57:37.000Z","date":"2024-11-19","kind":"sale","planned":true,"acquired":false,"shares":4156,"price":22.4102,"value":93136.7912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $21.95 to $22.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":93758,"source":{"system":"sec-edgar","filing":"0000950170-24-129452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024129452/ownership.xml","form_type":"4"}},{"id":1359310,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"exercise","planned":false,"acquired":false,"shares":6705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."}],"balance_after":87164,"derivative":{"underlying":"Common Stock","underlying_shares":6705},"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1359309,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"exercise","planned":false,"acquired":false,"shares":17369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":156315,"derivative":{"underlying":"Common Stock","underlying_shares":17369},"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1359308,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"exercise","planned":false,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":3786,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1359307,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"exercise","planned":false,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":779,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1359306,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":13077,"price":23.72,"value":310186.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,799 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":97914,"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1359305,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-11-19T23:06:20.000Z","date":"2024-11-16","kind":"exercise","planned":false,"acquired":true,"shares":25799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":110991,"source":{"system":"sec-edgar","filing":"0000950170-24-128888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024128888/ownership.xml","form_type":"4"}},{"id":1427738,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"exercise","planned":true,"acquired":false,"shares":6705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."}],"balance_after":93869,"derivative":{"underlying":"Common Stock","underlying_shares":6705},"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427737,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"exercise","planned":true,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":173684,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427736,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"exercise","planned":true,"acquired":false,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":4733,"derivative":{"underlying":"Common Stock","underlying_shares":946},"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427735,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"exercise","planned":true,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":1557,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427734,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":1698,"price":25.1288,"value":42668.7024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $24.91 to $25.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":85192,"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427733,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":2457,"price":24.3878,"value":59920.8246,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $23.91 to $24.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":86890,"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427732,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":13077,"price":24.4,"value":319078.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,797 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":89347,"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1427731,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:20.000Z","date":"2024-08-16","kind":"exercise","planned":true,"acquired":true,"shares":25797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 155 shares of the Issuer's Common Stock acquired by the Reporting Person on August 15, 2024 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":102424,"source":{"system":"sec-edgar","filing":"0000950170-24-099269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024099269/ownership.xml","form_type":"4"}},{"id":1511565,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":6704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024.  Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.  The RSUs have no expiration date."}],"balance_after":100574,"derivative":{"underlying":"Common Stock","underlying_shares":6704},"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511564,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":191052,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511563,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":5679,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511562,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":2335,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511561,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":1710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1710},"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511560,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":13943,"price":31.04,"value":432790.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 27,507 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":76472,"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1511559,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-05-17T20:09:25.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":true,"shares":27507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":90415,"source":{"system":"sec-edgar","filing":"0000950170-24-061638","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024061638/ownership.xml","form_type":"4"}},{"id":1576809,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-03-14T20:00:07.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":107278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2024, and thereafter, 1/16th of the underlying shares will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2024, and thereafter, 1/16th of the underlying shares will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":107278,"derivative":{"underlying":"Common Stock","underlying_shares":107278},"source":{"system":"sec-edgar","filing":"0000950170-24-031431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024031431/ownership.xml","form_type":"4"}},{"id":1576808,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-14T20:00:07.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":15442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/16th of the shares subject to this option vest and become excercsiable on May 16, 2024, and thereafter, 1/16th of the shares subject to this option will vest and become exercisable on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":15442,"derivative":{"exercise_price":28.7,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":15442},"source":{"system":"sec-edgar","filing":"0000950170-24-031431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024031431/ownership.xml","form_type":"4"}},{"id":1629493,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":17369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":208420,"derivative":{"underlying":"Common Stock","underlying_shares":17369},"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629492,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":6626,"derivative":{"underlying":"Common Stock","underlying_shares":946},"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629491,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vested with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares vested on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vested with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares vested on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24193},"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629490,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":3113,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629489,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":1710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":1710,"derivative":{"underlying":"Common Stock","underlying_shares":1710},"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629488,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":18919,"price":37.21,"value":703975.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":62908,"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1629487,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2024-02-21T21:04:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":44996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 121 shares of the Issuer's Common Stock acquired by the Reporting Person on February 15, 2024 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":81827,"source":{"system":"sec-edgar","filing":"0000950170-24-017895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000095017024017895/ownership.xml","form_type":"4"}},{"id":1734733,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":225789,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734732,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis,  subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis,  subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":7572,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734731,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":24193,"derivative":{"underlying":"Common Stock","underlying_shares":24193},"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734730,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":3891,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734729,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":1710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":3420,"derivative":{"underlying":"Common Stock","underlying_shares":1710},"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734728,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-17","kind":"sale","planned":true,"acquired":false,"shares":22685,"price":29.0967,"value":660058.6395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $28.55 to $29.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein."}],"balance_after":36710,"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734727,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":22311,"price":28.86,"value":643895.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":59395,"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1734726,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-11-20T21:00:58.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":true,"shares":44996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":81706,"source":{"system":"sec-edgar","filing":"0001209191-23-056015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123056015/doc4.xml","form_type":"4"}},{"id":1801988,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":243157,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801987,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis,  subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis,  subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":8519,"derivative":{"underlying":"Common Stock","underlying_shares":946},"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801986,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":48386,"derivative":{"underlying":"Common Stock","underlying_shares":24193},"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801985,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":4669,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801984,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":1709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":5130,"derivative":{"underlying":"Common Stock","underlying_shares":1709},"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801983,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":22683,"price":28.5877,"value":648454.7991,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $28.07 to $29.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein."}],"balance_after":36710,"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801982,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":22311,"price":29.8,"value":664867.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,994 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":59393,"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1801981,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-08-18T20:00:10.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":true,"shares":44994,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 302 shares acquired by the Reporting Person on August 15, 2023 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":81704,"source":{"system":"sec-edgar","filing":"0001209191-23-046512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123046512/doc4.xml","form_type":"4"}},{"id":1886942,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":false,"shares":17368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, such that all of the underlying shares shall be vested on February 16, 2027, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, such that all of the underlying shares shall be vested on February 16, 2027, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":260525,"derivative":{"underlying":"Common Stock","underlying_shares":17368},"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886941,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":9465,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886940,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":false,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":72579,"derivative":{"underlying":"Common Stock","underlying_shares":24193},"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886939,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":5447,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886938,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":false,"shares":1710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":6839,"derivative":{"underlying":"Common Stock","underlying_shares":1710},"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886937,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":24424,"price":14.0095,"value":342168.028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $13.83 to $14.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein."}],"balance_after":36408,"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886936,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":20572,"price":14.09,"value":289859.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":60832,"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1886935,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-05-18T20:02:33.000Z","date":"2023-05-16","kind":"exercise","planned":true,"acquired":true,"shares":44996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":81404,"source":{"system":"sec-edgar","filing":"0001209191-23-030581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123030581/doc4.xml","form_type":"4"}},{"id":1902926,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-05-05T20:01:30.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":64929,"price":14.18,"value":920693.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $13.63 to $14.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":36408,"source":{"system":"sec-edgar","filing":"0001209191-23-027626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123027626/doc4.xml","form_type":"4"}},{"id":1922992,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-04-07T20:42:47.000Z","date":"2023-04-05","kind":"sale","planned":true,"acquired":false,"shares":55500,"price":15.454,"value":857697.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $15.20 to $15.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":101337,"source":{"system":"sec-edgar","filing":"0001209191-23-023808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123023808/doc4.xml","form_type":"4"}},{"id":1974097,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-03-04T01:04:01.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":62692,"price":10.9607,"value":687148.2044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $10.79 to $11.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":156837,"source":{"system":"sec-edgar","filing":"0001209191-23-016060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123016060/doc4.xml","form_type":"4"}},{"id":2003722,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:16:34.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":10412,"derivative":{"underlying":"Common Stock","underlying_shares":946},"source":{"system":"sec-edgar","filing":"0001209191-23-011450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123011450/doc4.xml","form_type":"4"}},{"id":2003721,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:16:34.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."}],"balance_after":96772,"derivative":{"underlying":"Common Stock","underlying_shares":24193},"source":{"system":"sec-edgar","filing":"0001209191-23-011450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123011450/doc4.xml","form_type":"4"}},{"id":2003720,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:16:34.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":6225,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001209191-23-011450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123011450/doc4.xml","form_type":"4"}},{"id":2003719,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:16:34.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":1710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":8549,"derivative":{"underlying":"Common Stock","underlying_shares":1710},"source":{"system":"sec-edgar","filing":"0001209191-23-011450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123011450/doc4.xml","form_type":"4"}},{"id":2003718,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":34270,"kind":"person","name":"STEPHENSON BRIAN C","position":1,"cik":"0001780030","reported_name":"STEPHENSON BRIAN C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, Treasurer & CFO"}}],"security":"Common Stock","published_at":"2023-02-22T01:16:34.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":2150,"price":13.0646,"value":28088.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold from $13.04 to $13.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein."}],"balance_after":219529,"source":{"system":"sec-edgar","filing":"0001209191-23-011450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780030/000120919123011450/doc4.xml","form_type":"4"}}],"next_cursor":"2023-02-22T01:16:34.000000Z,2003718"}